• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
a lot of scissors
Biotech

Capricor, NextCure shed light on recent layoffs

Capricor and NextCure have shed light on recent rounds of layoffs, as the biotechs brace for a hoped-for drug approval and merger, respectively.
James Waldron Nov 11, 2026 4:48am
akt health

Why scientific progress depends on knowing when to look again

Brought to you by Ipsen
sickle cell disease

Beam’s sickle cell results signal Casgevy, Lyfgenia showdown

Nov 10, 2026 3:19pm
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories
Counsel Health and Oura image for ACCESS model
Favicon Fierce Healthcare

Oura to acquire AI virtual care partner Counsel Health for $625M

Nov 10, 2026 3:09pm
In Laboratory Over the Shoulder View of Scientist in Protective Clothes Doing Research on a Personal Computer

PepGen’s stock doubles as midphase DM1 data wow analysts

Nov 10, 2026 10:21am
More News

AstraZeneca buys partner Omniose for bacterial vaccine tech

Nov 10, 2026 10:16am

Fierce Biotech Fundraising Tracker '26: Oyster, Delix & more

Nov 10, 2026 10:00am

Mirum scores again in hep D phase 3, setting up FDA run

Nov 10, 2026 10:00am

Why experts fear fallout from Treasury’s China biotech crackdown

Nov 10, 2026 9:30am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings